NuVasive
nuvasive.comTotal trials
38
Active
9
Phase 3
3
Total enrollment
15,126
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Degenerative Disc Disease15
- Cervical Disc Disease5
- Spondylolisthesis4
- Degenerative Scoliosis4
- Cervical Degenerative Disc Disorder3
- Degenerative Spondylolisthesis3
- Radiculopathy2
- Myelopathy2
Frequently asked questions about NuVasive
- How many clinical trials does NuVasive have on ClinicalTrials.gov?
- NuVasive is listed as the lead sponsor on 38 clinical trials in ClinicalTrials.gov, 9 of which are currently active (recruiting, enrolling, or ongoing).
- How many of NuVasive's trials are in Phase 3?
- 3 of NuVasive's trials are in Phase 3.
- What therapeutic areas does NuVasive focus on?
- NuVasive's most-studied conditions on ClinicalTrials.gov are Degenerative Disc Disease, Cervical Disc Disease, Spondylolisthesis, Degenerative Scoliosis, Cervical Degenerative Disc Disorder.